Get started
SWING IDEA - AKZO NOBEL INDIA Akzo Nobel India , a subsidiary of the global paints and coatings giant AkzoNobel N.V., is a leading player in India’s decorative and industrial paints market. Known for its premium brand Dulux , the company has strong brand recall, a wide distribution network, and consistent profitability.A strong brand, steady margins, and a bullish chart make this a candidate to watch for a short- to medium-term swing trade. Reasons are listed below : Bullish engulfing candle spotted on the weekly timeframe, signaling a potential trend reversal. Accompanied by the highest-ever volume spike, adding strong conviction to the move. Price is bouncing off the golden Fibonacci support (0.618), a classic retracement zone where strong reversals often occur. The level of 3100 acted as a solid support. The stock is trading above its 50 & 200 EMA on the weekly chart — a sign of long-term strength. Target - 3812 // 4520 Stoploss - weekly close below 3000 DISCLAIMER - Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services. @visionary.growth.insights
NSE:AKZOINDIALong
by Visionary_Growth_Insights
RELIANCE: Strong Resistance at ₹1600 — Covered Call Setup📉 Chart Context: Reliance recently rallied ~25% from lows near ₹1,150 to ₹1,450. The rally stalled at the broken lower trendline of a long-term channel, turning resistance. Price action now showing rejection around ₹1,435–₹1,450 zone — a historical supply area. 📊 Derivatives Insight: July ₹1600 CE has the highest Open Interest across the chain: 3.6 lakh+ contracts. This strike acts as a clear ceiling for market participants. IV for ₹1600 CE is elevated at 21.8%, indicating overpricing of far OTM risk. 📈 Strategy: Strategy Bias: Neutral / Mildly Bearish ⚠️ Note: This strategy is suitable only for investors already holding a sizeable position (≥500 shares) in Reliance. It is not a recommendation to buy the stock solely for option writing. With 500+ shares held, this aligns perfectly for a covered call: Sell July ₹1600 CE at ₹7.20 Generate passive income (~₹3,600/lot) while capping gains ~13% above CMP Play on sideways or weakening structure without exiting core position ⚠️ Risk Management: If Reliance breaches ₹1600 before expiry, gains above this are capped Position sizing and pledge margin must be managed correctly 📌 Conclusion: This is a textbook low-risk income strategy using technical resistance, OI data, and IV edge. Unless a fresh breakout emerges, ₹1600 stands firm. Disclaimer: T his analysis is for educational and informational purposes only. It does not constitute investment advice or a recommendation. Options trading involves risk. Always do your own research or consult a financial advisor before making decisions.
NSE:RELIANCE
by eggubonda
[Long-Term]LICI Rising Channel Pattern Indicates Bullish OutlookIn this monthly chart of LICI, we observe a clear ascending channel pattern forming over the past two years. The price has consistently respected both the support and resistance trendlines, creating a strong bullish structure. Currently, the stock is bouncing off the lower support trendline, indicating a potential upward move towards the upper resistance zone. This offers a positive long-term outlook, especially if the momentum sustains. The key levels to watch are: Support Zone: Around ₹850–₹900 Resistance Zone: ₹1250–₹1300 Traders and investors can monitor for a gradual rise toward the resistance level. A breakout beyond this channel may open up new highs, while a breakdown below the support trendline would invalidate the pattern.
NSE:LICILong
by TradZoo
ALBERT DAVIDAlbert David Ltd. is a pharmaceutical company engaged in the manufacturing and marketing of formulations, bulk drugs, and healthcare solutions. It serves domestic and export markets with products across therapeutic areas such as gastroenterology, gynecology, and general medicine. The stock is currently trading at INR 881.55, showing signs of upward momentum following a period of consolidation. Key Levels Support Levels: INR 758.00, INR 970.50, INR 1,141.30 Swing Level: INR 881.55 Possible Upside: INR 1,545.65, INR 1,758.55, INR 2,027.70 Technical Indicators RSI (Relative Strength Index): Currently at 46.17, suggesting neutral momentum. A break above the mid-50s range would confirm growing strength. Volume: At 21.34K, the rising volume alongside recent price uptick signals early signs of accumulation and potential trend development. Sector and Market Outlook Albert David operates in India’s formulation-driven pharmaceutical sector, which is buoyed by: Consistent domestic demand for generics and branded formulations Increased R&D investments for differentiated dosage forms and APIs Evolving export strategy amid global interest in Indian pharma suppliers Challenges include pricing caps by regulators, raw material import reliance (especially for APIs), and generic competition from larger incumbents. Latest Developments Manufacturing Upgrade: Recent investments in facility modernization to meet evolving GMP standards Product Portfolio Expansion: Strengthening presence in anti-infectives and critical care segments Earnings Performance: Sequential growth in operating margins with a focus on efficiency and therapeutic diversification Dividend Update Albert David Ltd. has maintained a consistent payout strategy, most recently declaring a dividend of ₹5.00 per share, reflecting stable fundamentals and shareholder alignment. Analysis Summary Albert David Ltd. is exhibiting a technically constructive setup within the broader pharma space. While momentum remains neutral, increasing volume and structural stability support a positive outlook. With improving fundamentals and rising investor participation, the stock may be entering a base-building phase with scope for medium-term trend development as sector sentiment strengthens.
NSE:ALBERTDAVDLong
by TechnicalAnalystSucrit